IGM Biosciences' stock is trading higher due to the successful pricing of its upsized public offering and concurrent private placement at $8.00 per share. This move is expected to raise approximately $107.3 million, which will likely be used to fund the company's operations and growth. The market is reacting positively to this news, as it indicates that the company is able to raise capital and has a strong financial position.